跳至主要内容
临床试验/NCT07147829
NCT07147829尚未招募不适用

Digital Silence and Mental Health: The Effects of a Digital Detox Intervention on Depression, Stress, Anxiety, Sleep Quality, and Emotion Regulation in Young Adults: A Randomized Controlled Trial

Ataturk University0 个研究点目标入组 100 人开始时间: 2025年10月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
100
主要终点
DASS 21

研究概览

简要总结

Social media use has been linked to negative mental health outcomes, including increased anxiety, depression, stress, poor sleep quality, and difficulties in emotion regulation. Digital detox interventions, which involve reducing or temporarily eliminating digital engagement, have emerged as a strategy to mitigate these effects. However, current evidence regarding their effectiveness is mixed and limited by short-term follow-ups and methodological variability. This study aims to examine the impact of a digital detox intervention on depression, anxiety, stress, sleep quality, and emotion regulation in young adults.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 25 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Owning a smartphone
  • Using social media for ≥ 8 hours per day
  • Not having a diagnosis related to anxiety, depression, stress, sleep, or emotional regulation
  • Living in an environment with internet access
  • Providing voluntary informed consent

排除标准

  • Having a history of psychiatric diagnosis
  • Currently using psychiatric medication
  • Having received psychological counseling in the past 6 months
  • Having a diagnosis of sleep disorder

结局指标

主要结局

DASS 21

时间窗: 30 day

The DASS-21 was developed by Lovibond and Lovibond as a shortened version of the DASS-42. The psychometric properties of the Turkish version of the Depression Anxiety Stress-21 (DASS-21) scale in both clinical and non-clinical samples were examined by Sarıçam. In the non-clinical sample, the test-retest correlation coefficients were found to be r = 0.68 for the depression subscale, r = 0.66 for the anxiety subscale, and r = 0.61 for the stress subscale. This scale is a 4-point Likert-type instrument consisting of seven items for each of the three dimensions: depression, anxiety, and stress. A score of 5 or above on the depression subscale, 4 or above on the anxiety subscale, and 8 or above on the stress subscale indicates the presence of the respective problem

PUKİ

时间窗: 30 day

The Pittsburgh Sleep Quality Index (PSQI) was developed by Buysse et al. and its validity and reliability in Turkey were established by Ağargün et al. The scale assesses an individual's sleep quality over the past month and consists of 24 items. Nineteen of these are self-report questions, and 18 items are scored across seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Each item is rated on a 0-3 scale, with total scores ranging from 0 to 21. Scores of 5 or below indicate "good sleep quality," while scores above 5 indicate "poor sleep quality." The scale demonstrates a high level of internal consistency with a Cronbach's alpha of 0.80, and its diagnostic sensitivity (89.6%) and specificity (86.5%) are also high.

DASS 21

时间窗: 30 day

The DASS-21 was developed by Lovibond and Lovibond as a shortened version of the DASS-42. The psychometric properties of the Turkish version of the Depression Anxiety Stress-21 (DASS-21) scale in both clinical and non-clinical samples were examined by Sarıçam. In the non-clinical sample, the test-retest correlation coefficients were found to be r = 0.68 for the depression subscale, r = 0.66 for the anxiety subscale, and r = 0.61 for the stress subscale. This scale is a 4-point Likert-type instrument consisting of seven items for each of the three dimensions: depression, anxiety, and stress. A score of 5 or above on the depression subscale, 4 or above on the anxiety subscale, and 8 or above on the stress subscale indicates the presence of the respective problem

PUKİ

时间窗: 30 day

The Pittsburgh Sleep Quality Index (PSQI) was developed by Buysse et al. and its validity and reliability in Turkey were established by Ağargün et al. The scale assesses an individual's sleep quality over the past month and consists of 24 items. Nineteen of these are self-report questions, and 18 items are scored across seven components: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction. Each item is rated on a 0-3 scale, with total scores ranging from 0 to 21. Scores of 5 or below indicate "good sleep quality," while scores above 5 indicate "poor sleep quality." The scale demonstrates a high level of internal consistency with a Cronbach's alpha of 0.80, and its diagnostic sensitivity (89.6%) and specificity (86.5%) are also high.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Ceylan Aksoy

Principal Investigator

Agri Ibrahim Cecen University

相似试验